Difficulty: Medium
Average Score: 93%
Testbank
The nurse is relating medication classifications for Alzheimer type dementia to the pathophysiology of the disease process. Which neurotransmitter do most the medications on the market currently impact?
Correct answer
B
Rationale
Acetylcholine is the primary neurotransmitter that most medications for Alzheimer type dementia target to improve cognitive function.
Acetylcholine plays a crucial role in memory and learning, and its deficiency is associated with the cognitive decline seen in Alzheimer's disease. Medications like cholinesterase inhibitors work by increasing acetylcholine availability in the synaptic cleft, thereby enhancing cholinergic neurotransmission and potentially alleviating some symptoms of the disease.
A: Dopamine is primarily associated with movement and reward pathways and is not the main focus of Alzheimer’s treatment, which centers on cognitive symptoms rather than motor control.
C: Norepinephrine is involved in attention and response actions but does not directly address the cholinergic deficits seen in Alzheimer’s, making it less relevant for this type of dementia.
D: Epinephrine primarily functions in the body’s fight-or-flight response and does not play a significant role in the cognitive processes affected by Alzheimer’s disease, thus not being a target for current medications.
Acetylcholine plays a crucial role in memory and learning, and its deficiency is associated with the cognitive decline seen in Alzheimer's disease. Medications like cholinesterase inhibitors work by increasing acetylcholine availability in the synaptic cleft, thereby enhancing cholinergic neurotransmission and potentially alleviating some symptoms of the disease.
A: Dopamine is primarily associated with movement and reward pathways and is not the main focus of Alzheimer’s treatment, which centers on cognitive symptoms rather than motor control.
C: Norepinephrine is involved in attention and response actions but does not directly address the cholinergic deficits seen in Alzheimer’s, making it less relevant for this type of dementia.
D: Epinephrine primarily functions in the body’s fight-or-flight response and does not play a significant role in the cognitive processes affected by Alzheimer’s disease, thus not being a target for current medications.